Cargando…

Clinical value of folate receptor-positive circulating tumor cells in patients with esophageal squamous cell carcinomas: a retrospective study

BACKGROUND: The aim of the study is to explore the role of preoperative folate receptor-positive circulating tumor cell (FR(+)CTC) levels in predicting disease-free survival (DFS) and overall survival (OS) in patients with esophageal squamous cell carcinomas (ESCC). METHODS: Three ml blood samples w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Qiang, He, Qiao, He, Wenwu, Wang, Chenghao, Liu, Guangyuan, Wang, Kangning, Li, Haojun, Li, Jialong, Xiao, Wenguang, Fang, Qiang, Peng, Lin, Han, Yongtao, Wang, Dongsheng, Leng, Xuefeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10687783/ https://www.ncbi.nlm.nih.gov/pubmed/38037003 http://dx.doi.org/10.1186/s12885-023-11565-z

Ejemplares similares

Resected lymph nodes and survival of patients with esophageal squamous cell carcinoma: an observational study
por: Li, Kexun, et al.
Publicado: (2023)

The efficacy and safety of neoadjuvant immunotherapy in resectable locally advanced esophageal squamous cell carcinoma: A systematic review and meta-analysis
por: He, Wenwu, et al.
Publicado: (2023)

Toripalimab Plus Paclitaxel and Carboplatin as Neoadjuvant Therapy in Locally Advanced Resectable Esophageal Squamous Cell Carcinoma
por: He, Wenwu, et al.
Publicado: (2022)

Tislelizumab Plus Chemotherapy Sequential Neoadjuvant Therapy for Non-cCR Patients After Neoadjuvant Chemoradiotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma (ETNT): An Exploratory Study
por: He, Wenwu, et al.
Publicado: (2022)

Genetic Heterogeneity of Esophageal Squamous Cell Carcinoma with Inherited Family History
por: He, Wenwu, et al.
Publicado: (2020)

miRNA-9 Inhibits Proliferation and Migration of Lung Squamous Cell Carcinoma Cells by Regulating NRSF/EGFR
por: Wang, Kangning, et al.
Publicado: (2020)

Impact of two‑field or three‑field lymphadenectomy on overall survival in middle and lower thoracic esophageal squamous cell carcinoma: A single‑center retrospective analysis
por: Li, Kexun, et al.
Publicado: (2023)

Network and pathway-based analysis of genes associated with esophageal squamous cell carcinoma
por: He, Wenwu, et al.
Publicado: (2023)

Identification of tumor-infiltrating lymphocyte subpopulations correlated with patient prognosis in esophageal squamous cell carcinoma
por: Peng, Lin, et al.
Publicado: (2021)

The impact of adjuvant therapy on survival for node-negative esophageal squamous cell carcinoma: a propensity score-matched analysis
por: Deng, Xuyang, et al.
Publicado: (2021)

Moderately differentiated esophageal squamous cell carcinoma has a poor prognosis after neoadjuvant chemoradiotherapy
por: He, Wenwu, et al.
Publicado: (2021)

A five-gene signature to predict the overall survival time of patients with esophageal squamous cell carcinoma
por: He, Wenwu, et al.
Publicado: (2019)

Optimal discharge planning for esophagectomy patients with enhanced recovery after surgery: Recommendations
por: Li, Kunzhi, et al.
Publicado: (2023)

Folate Receptor 4-Expressing T cell Is Associated with Disease-Free Survival in Patients with Esophageal Squamous Cell Carcinoma
por: Zhang, Xiangmei, et al.
Publicado: (2022)

MMS22L Expression as a Predictive Biomarker for the Efficacy of Neoadjuvant Chemoradiotherapy in Oesophageal Squamous Cell Carcinoma
por: Luo, Qiyu, et al.
Publicado: (2021)

Development and Validation of a Recurrence-Free Survival Prediction Model for Locally Advanced Esophageal Squamous Cell Carcinoma with Neoadjuvant Chemoradiotherapy
por: Zhou, Yehan, et al.
Publicado: (2023)

Analysis of risk factors for pulmonary infection in patients with minimally invasive esophagectomy
por: Liu, Guangyuan, et al.
Publicado: (2019)

Reliability and safety of minimally invasive esophagectomy after neoadjuvant chemoradiation: a retrospective study
por: Liu, Guangyuan, et al.
Publicado: (2019)

A prognostic nomogram that includes MPV in esophageal squamous cell carcinoma
por: He, Qiao, et al.
Publicado: (2023)

Circulating exosomes from esophageal squamous cell carcinoma mediate the generation of B10 and PD‐1(high) Breg cells
por: Mao, Yu, et al.
Publicado: (2019)

Prognostic value of circulating tumor cells in the peripheral blood of patients with esophageal squamous cell carcinoma
por: Qiao, Yuanyuan, et al.
Publicado: (2017)

Folate-Receptor Positive Circulating Tumor Cell Is a Potential Diagnostic Marker of Prostate Cancer
por: Lian, Shenyi, et al.
Publicado: (2021)

Diet folate, DNA methylation and genetic polymorphisms of MTHFR C677T in association with the prognosis of esophageal squamous cell carcinoma
por: Lu, Cheng, et al.
Publicado: (2011)

The utility of folate receptor-positive circulating tumor cell in cancer diagnosis in the elderly population
por: Li, Na, et al.
Publicado: (2019)

The current state of artificial intelligence in endoscopic diagnosis of early esophageal squamous cell carcinoma
por: Pan, Yuwei, et al.
Publicado: (2023)

EUS–derived maximum tumor thickness and tumor shrinkage rate as independent prognostic factors in locally advanced esophageal squamous cell carcinoma after neoadjuvant chemoradiotherapy
por: Chen, Xue, et al.
Publicado: (2023)

Prognostic and incremental value of computed tomography-based radiomics from tumor and nodal regions in esophageal squamous cell carcinoma
por: Cao, Bangrong, et al.
Publicado: (2022)

Prognostic value of nutritional and inflammatory indicators in females with esophageal squamous cell cancer: A propensity score matching study
por: Li, Yuping, et al.
Publicado: (2022)

Folate intake, serum folate levels and esophageal cancer risk: an overall and dose-response meta-analysis
por: Zhao, Yan, et al.
Publicado: (2017)

Postoperative adjuvant chemotherapy versus chemoradiotherapy for node-positive esophageal squamous cell carcinoma: a propensity score-matched analysis
por: Wang, Qifeng, et al.
Publicado: (2020)

Clinical Significance of Monitoring Circulating Free DNA and Plasma Heat Shock Protein 90alpha in Patients with Esophageal Squamous Cell Carcinoma
por: Zhao, Qiang, et al.
Publicado: (2021)

Folate receptor‐positive circulating tumor cells in the preoperative diagnosis of indeterminate pulmonary nodules
por: Li, Zhixin, et al.
Publicado: (2022)

A preliminary study of the clinical significance of folate receptor-positive circulating tumor cell in the management of hepatobiliary-pancreatic cancers
por: He, Yong-gang, et al.
Publicado: (2020)

Detection of folate receptor‐positive circulating tumor cells as a biomarker for diagnosis, prognostication, and therapeutic monitoring in breast cancer
por: Wu, Qian, et al.
Publicado: (2021)

Folate receptor-positive circulating tumor cells predict survival and recurrence patterns in patients undergoing resection for pancreatic cancer
por: Cheng, Hao, et al.
Publicado: (2022)

Clinical Significance of Folate Receptor-positive Circulating Tumor Cells Detected by Ligand-targeted Polymerase Chain Reaction in Lung Cancer
por: Wang, Lin, et al.
Publicado: (2017)

Clinical Utility of Circulating Tumor Cells in Patients With Esophageal Cancer
por: Li, Yang, et al.
Publicado: (2022)

The value of folate receptor-positive circulating tumour cells as a diagnostic biomarker for lung cancer: a systematic review and meta-analysis
por: Chen, Fangjun, et al.
Publicado: (2023)

Downregulation of H19 decreases the radioresistance in esophageal squamous cell carcinoma cells
por: Luo, Wenguang, et al.
Publicado: (2019)

Safety and efficacy of paclitaxel plus carboplatin versus paclitaxel plus cisplatin in neoadjuvant chemoradiotherapy for patients with locally advanced esophageal carcinoma: a retrospective study
por: Jiang, Li, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hkb8r4lh6i1mm2qtpkdrf1pj5j